Global Livestock mRNA Vaccines Market Insights, Forecast to 2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Livestock mRNA Vaccines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Livestock mRNA Vaccines Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Injectable Drug Administration
  • 1.2.3 Non-invasive Drug Administration
• 1.3 Market by Application
  • 1.3.1 Global Livestock mRNA Vaccines Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Cattle
  • 1.3.3 Pigs
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Livestock mRNA Vaccines Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Livestock mRNA Vaccines Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Livestock mRNA Vaccines Revenue by Region (2020-2031)
  • 2.2.3 Global Livestock mRNA Vaccines Revenue Market Share by Region (2020-2031)
• 2.3 Global Livestock mRNA Vaccines Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Livestock mRNA Vaccines Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Livestock mRNA Vaccines Sales by Region (2020-2031)
  • 2.4.3 Global Livestock mRNA Vaccines Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Livestock mRNA Vaccines Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Livestock mRNA Vaccines Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Livestock mRNA Vaccines in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Livestock mRNA Vaccines Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Livestock mRNA Vaccines Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 10 and Top 5 Companies by Livestock mRNA Vaccines Revenue in 2024
• 3.3 Global Key Players of Livestock mRNA Vaccines, Industry Ranking, 2023 VS 2024
• 3.4 Global Livestock mRNA Vaccines Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Livestock mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Livestock mRNA Vaccines, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Livestock mRNA Vaccines, Product Offered and Application
• 3.8 Global Key Manufacturers of Livestock mRNA Vaccines, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Sales by Type
  • 4.1.1 Global Livestock mRNA Vaccines Historical Sales by Type (2020-2025)
  • 4.1.2 Global Livestock mRNA Vaccines Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Livestock mRNA Vaccines Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Livestock mRNA Vaccines Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Livestock mRNA Vaccines Price by Type (2020-2025)
  • 4.3.2 Global Livestock mRNA Vaccines Price Forecast by Type (2026-2031)

5 Market Size by Application

• 5.1 Global Sales by Application
  • 5.1.1 Global Livestock mRNA Vaccines Historical Sales by Application (2020-2025)
  • 5.1.2 Global Livestock mRNA Vaccines Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Livestock mRNA Vaccines Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Livestock mRNA Vaccines Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Livestock mRNA Vaccines Price by Application (2020-2025)
  • 5.3.2 Global Livestock mRNA Vaccines Price Forecast by Application (2026-2031)

6 US & Canada

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Livestock mRNA Vaccines Sales by Type (2020-2031)
  • 6.1.2 US & Canada Livestock mRNA Vaccines Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Livestock mRNA Vaccines Sales by Application (2020-2031)
  • 6.2.2 US & Canada Livestock mRNA Vaccines Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Livestock mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Livestock mRNA Vaccines Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Livestock mRNA Vaccines Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Livestock mRNA Vaccines Sales by Type (2020-2031)
  • 7.1.2 Europe Livestock mRNA Vaccines Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Livestock mRNA Vaccines Sales by Application (2020-2031)
  • 7.2.2 Europe Livestock mRNA Vaccines Revenue by Application (2020-2031)
• 7.3 Europe Market Size by Country
  • 7.3.1 Europe Livestock mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031
  • 7.3.2 Europe Livestock mRNA Vaccines Sales by Country (2020-2031)
  • 7.3.3 Europe Livestock mRNA Vaccines Revenue by Country (2020-2031)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Market Size by Type
  • 8.1.1 China Livestock mRNA Vaccines Sales by Type (2020-2031)
  • 8.1.2 China Livestock mRNA Vaccines Revenue by Type (2020-2031)
• 8.2 China Market Size by Application
  • 8.2.1 China Livestock mRNA Vaccines Sales by Application (2020-2031)
  • 8.2.2 China Livestock mRNA Vaccines Revenue by Application (2020-2031)

9 Asia (excluding China)

• 9.1 Asia Market Size by Type
  • 9.1.1 Asia Livestock mRNA Vaccines Sales by Type (2020-2031)
  • 9.1.2 Asia Livestock mRNA Vaccines Revenue by Type (2020-2031)
• 9.2 Asia Market Size by Application
  • 9.2.1 Asia Livestock mRNA Vaccines Sales by Application (2020-2031)
  • 9.2.2 Asia Livestock mRNA Vaccines Revenue by Application (2020-2031)
• 9.3 Asia Market Size by Region
  • 9.3.1 Asia Livestock mRNA Vaccines Revenue by Region: 2020 VS 2024 VS 2031
  • 9.3.2 Asia Livestock mRNA Vaccines Revenue by Region (2020-2031)
  • 9.3.3 Asia Livestock mRNA Vaccines Sales by Region (2020-2031)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Livestock mRNA Vaccines Sales by Type (2020-2031)
  • 10.1.2 Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue by Type (2020-2031)
• 10.2 Middle East, Africa and Latin America Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Livestock mRNA Vaccines Sales by Application (2020-2031)
  • 10.2.2 Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue by Application (2020-2031)
• 10.3 Middle East, Africa and Latin America Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue by Country: 2020 VS 2024 VS 2031
  • 10.3.2 Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue by Country (2020-2031)
  • 10.3.3 Middle East, Africa and Latin America Livestock mRNA Vaccines Sales by Country (2020-2031)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Ceva Animal Health
  • 11.1.1 Ceva Animal Health Company Information
  • 11.1.2 Ceva Animal Health Overview
  • 11.1.3 Ceva Animal Health Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.1.4 Ceva Animal Health Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Ceva Animal Health Recent Developments
• 11.2 Merck Animal Health
  • 11.2.1 Merck Animal Health Company Information
  • 11.2.2 Merck Animal Health Overview
  • 11.2.3 Merck Animal Health Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.2.4 Merck Animal Health Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Merck Animal Health Recent Developments
• 11.3 Areterna
  • 11.3.1 Areterna Company Information
  • 11.3.2 Areterna Overview
  • 11.3.3 Areterna Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.3.4 Areterna Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Areterna Recent Developments
• 11.4 Bayer
  • 11.4.1 Bayer Company Information
  • 11.4.2 Bayer Overview
  • 11.4.3 Bayer Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.4.4 Bayer Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Bayer Recent Developments
• 11.5 BioNTech
  • 11.5.1 BioNTech Company Information
  • 11.5.2 BioNTech Overview
  • 11.5.3 BioNTech Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.5.4 BioNTech Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 BioNTech Recent Developments
• 11.6 Genvax Technologies
  • 11.6.1 Genvax Technologies Company Information
  • 11.6.2 Genvax Technologies Overview
  • 11.6.3 Genvax Technologies Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.6.4 Genvax Technologies Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Genvax Technologies Recent Developments
• 11.7 BioVenic
  • 11.7.1 BioVenic Company Information
  • 11.7.2 BioVenic Overview
  • 11.7.3 BioVenic Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.7.4 BioVenic Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 BioVenic Recent Developments
• 11.8 Moderna
  • 11.8.1 Moderna Company Information
  • 11.8.2 Moderna Overview
  • 11.8.3 Moderna Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.8.4 Moderna Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Moderna Recent Developments
• 11.9 Ruipu Biotechnology
  • 11.9.1 Ruipu Biotechnology Company Information
  • 11.9.2 Ruipu Biotechnology Overview
  • 11.9.3 Ruipu Biotechnology Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.9.4 Ruipu Biotechnology Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Ruipu Biotechnology Recent Developments
• 11.10 Jinyu Bio-technology
  • 11.10.1 Jinyu Bio-technology Company Information
  • 11.10.2 Jinyu Bio-technology Overview
  • 11.10.3 Jinyu Bio-technology Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.10.4 Jinyu Bio-technology Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Jinyu Bio-technology Recent Developments
• 11.11 Shanghai Shen Lian Biomedical
  • 11.11.1 Shanghai Shen Lian Biomedical Company Information
  • 11.11.2 Shanghai Shen Lian Biomedical Overview
  • 11.11.3 Shanghai Shen Lian Biomedical Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.11.4 Shanghai Shen Lian Biomedical Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Shanghai Shen Lian Biomedical Recent Developments
• 11.12 Suzhou Kerui Meide Biomedical Technology
  • 11.12.1 Suzhou Kerui Meide Biomedical Technology Company Information
  • 11.12.2 Suzhou Kerui Meide Biomedical Technology Overview
  • 11.12.3 Suzhou Kerui Meide Biomedical Technology Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.12.4 Suzhou Kerui Meide Biomedical Technology Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Suzhou Kerui Meide Biomedical Technology Recent Developments
• 11.13 Shanghai Rnacure Biopharma
  • 11.13.1 Shanghai Rnacure Biopharma Company Information
  • 11.13.2 Shanghai Rnacure Biopharma Overview
  • 11.13.3 Shanghai Rnacure Biopharma Livestock mRNA Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
  • 11.13.4 Shanghai Rnacure Biopharma Livestock mRNA Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Shanghai Rnacure Biopharma Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Livestock mRNA Vaccines Industry Chain Analysis
• 12.2 Livestock mRNA Vaccines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Livestock mRNA Vaccines Production Mode & Process
• 12.4 Livestock mRNA Vaccines Sales and Marketing
  • 12.4.1 Livestock mRNA Vaccines Sales Channels
  • 12.4.2 Livestock mRNA Vaccines Distributors
• 12.5 Livestock mRNA Vaccines Customers

13 Livestock mRNA Vaccines Market Dynamics

• 13.1 Livestock mRNA Vaccines Industry Trends
• 13.2 Livestock mRNA Vaccines Market Drivers
• 13.3 Livestock mRNA Vaccines Market Challenges
• 13.4 Livestock mRNA Vaccines Market Restraints

14 Key Findings in the Global Livestock mRNA Vaccines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Livestock mRNA Vaccines Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of Injectable Drug Administration

Table 3. Major Manufacturers of Non-invasive Drug Administration

Table 4. Global Livestock mRNA Vaccines Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 5. Global Livestock mRNA Vaccines Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 6. Global Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Revenue Market Share by Region (2020-2031)

Table 8. Global Livestock mRNA Vaccines Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)

Table 9. Global Livestock mRNA Vaccines Sales by Region (2020-2031) & (K Dose)

Table 10. Global Sales Market Share by Region (2020-2031)

Table 11. Global Livestock mRNA Vaccines Sales by Manufacturers (2020-2025) & (K Dose)

Table 12. Global Livestock mRNA Vaccines Sales Share by Manufacturers (2020-2025)

Table 13. Global Livestock mRNA Vaccines Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 14. Global Livestock mRNA Vaccines Revenue Market Share by Manufacturers (2020-2025)

Table 15. Global Key Players of Livestock mRNA Vaccines, Industry Ranking, 2023 VS 2024 VS 2024

Table 16. Livestock mRNA Vaccines Price by Manufacturers (2020-2025) & (US$/Dose)

Table 17. Global Livestock mRNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 18. Global Livestock mRNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Livestock mRNA Vaccines as of 2024)

Table 19. Global Key Manufacturers of Livestock mRNA Vaccines, Manufacturing Base Distribution and Headquarters

Table 20. Global Key Manufacturers of Livestock mRNA Vaccines, Product Offered and Application

Table 21. Global Key Manufacturers of Livestock mRNA Vaccines, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Livestock mRNA Vaccines Sales by Type (2020-2025) & (K Dose)

Table 24. Global Livestock mRNA Vaccines Sales by Type (2026-2031) & (K Dose)

Table 25. Global Sales Share by Type (2020-2031)

Table 26. Global Livestock mRNA Vaccines Revenue by Type (2020-2025) & (US$ Million)

Table 27. Global Livestock mRNA Vaccines Revenue by Type (2026-2031) & (US$ Million)

Table 28. Global Revenue Share by Type (2020-2031)

Table 29. Livestock mRNA Vaccines Price by Type (2020-2025) & (US$/Dose)

Table 30. Global Livestock mRNA Vaccines Price Forecast by Type (2026-2031) & (US$/Dose)

Table 31. Global Livestock mRNA Vaccines Sales by Application (2020-2025) & (K Dose)

Table 32. Global Livestock mRNA Vaccines Sales by Application (2026-2031) & (K Dose)

Table 33. Global Sales Share by Application (2020-2031)

Table 34. Global Livestock mRNA Vaccines Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Livestock mRNA Vaccines Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Revenue Share by Application (2020-2031)

Table 37. Livestock mRNA Vaccines Price by Application (2020-2025) & (US$/Dose)

Table 38. Global Livestock mRNA Vaccines Price Forecast by Application (2026-2031) & (US$/Dose)

Table 39. US & Canada Sales by Type (2020-2031) & (K Dose)

Table 40. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 41. US & Canada Sales by Application (2020-2031) & (K Dose)

Table 42. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 43. US & Canada Livestock mRNA Vaccines Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 45. US & Canada Sales by Country (2020-2031) & (K Dose)

Table 46. Europe Sales by Type (2020-2031) & (K Dose)

Table 47. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 48. Europe Sales by Application (2020-2031) & (K Dose)

Table 49. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 50. Europe Livestock mRNA Vaccines Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 51. Europe Sales by Country (2020-2031) & (K Dose)

Table 52. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 53. China Sales by Type (2020-2031) & (K Dose)

Table 54. China Revenue by Type (2020-2031) & (US$ Million)

Table 55. China Sales by Application (2020-2031) & (K Dose)

Table 56. China Revenue by Application (2020-2031) & (US$ Million)

Table 57. Asia Sales by Type (2020-2031) & (K Dose)

Table 58. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 59. Asia Sales by Application (2020-2031) & (K Dose)

Table 60. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 61. Asia Livestock mRNA Vaccines Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 62. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 63. Asia Sales by Region (2020-2031) & (K Dose)

Table 64. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Dose)

Table 65. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 66. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Dose)

Table 67. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 69. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Dose)

Table 71. Ceva Animal Health Company Information

Table 72. Ceva Animal Health Description and Major Businesses

Table 73. Ceva Animal Health Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 74. Ceva Animal Health Product Model Numbers, Pictures, Descriptions and Specifications

Table 75. Ceva Animal Health Recent Developments

Table 76. Merck Animal Health Company Information

Table 77. Merck Animal Health Description and Major Businesses

Table 78. Merck Animal Health Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 79. Merck Animal Health Product Model Numbers, Pictures, Descriptions and Specifications

Table 80. Merck Animal Health Recent Developments

Table 81. Areterna Company Information

Table 82. Areterna Description and Major Businesses

Table 83. Areterna Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 84. Areterna Product Model Numbers, Pictures, Descriptions and Specifications

Table 85. Areterna Recent Developments

Table 86. Bayer Company Information

Table 87. Bayer Description and Major Businesses

Table 88. Bayer Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 89. Bayer Product Model Numbers, Pictures, Descriptions and Specifications

Table 90. Bayer Recent Developments

Table 91. BioNTech Company Information

Table 92. BioNTech Description and Major Businesses

Table 93. BioNTech Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 94. BioNTech Product Model Numbers, Pictures, Descriptions and Specifications

Table 95. BioNTech Recent Developments

Table 96. Genvax Technologies Company Information

Table 97. Genvax Technologies Description and Major Businesses

Table 98. Genvax Technologies Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 99. Genvax Technologies Product Model Numbers, Pictures, Descriptions and Specifications

Table 100. Genvax Technologies Recent Developments

Table 101. BioVenic Company Information

Table 102. BioVenic Description and Major Businesses

Table 103. BioVenic Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 104. BioVenic Product Model Numbers, Pictures, Descriptions and Specifications

Table 105. BioVenic Recent Developments

Table 106. Moderna Company Information

Table 107. Moderna Description and Major Businesses

Table 108. Moderna Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 109. Moderna Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. Moderna Recent Developments

Table 111. Ruipu Biotechnology Company Information

Table 112. Ruipu Biotechnology Description and Major Businesses

Table 113. Ruipu Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 114. Ruipu Biotechnology Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Ruipu Biotechnology Recent Developments

Table 116. Jinyu Bio-technology Company Information

Table 117. Jinyu Bio-technology Description and Major Businesses

Table 118. Jinyu Bio-technology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 119. Jinyu Bio-technology Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Jinyu Bio-technology Recent Developments

Table 121. Shanghai Shen Lian Biomedical Company Information

Table 122. Shanghai Shen Lian Biomedical Description and Major Businesses

Table 123. Shanghai Shen Lian Biomedical Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 124. Shanghai Shen Lian Biomedical Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Shanghai Shen Lian Biomedical Recent Developments

Table 126. Suzhou Kerui Meide Biomedical Technology Company Information

Table 127. Suzhou Kerui Meide Biomedical Technology Description and Major Businesses

Table 128. Suzhou Kerui Meide Biomedical Technology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 129. Suzhou Kerui Meide Biomedical Technology Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Suzhou Kerui Meide Biomedical Technology Recent Developments

Table 131. Shanghai Rnacure Biopharma Company Information

Table 132. Shanghai Rnacure Biopharma Description and Major Businesses

Table 133. Shanghai Rnacure Biopharma Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 134. Shanghai Rnacure Biopharma Product Model Numbers, Pictures, Descriptions and Specifications

Table 135. Shanghai Rnacure Biopharma Recent Developments

Table 136. Key Raw Materials Lists

Table 137. Raw Materials Key Suppliers Lists

Table 138. Distributors List

Table 139. Customers List

Table 140. Market Trends

Table 141. Market Drivers

Table 142. Market Challenges

Table 143. Market Restraints

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Livestock mRNA Vaccines Product Picture

Figure 2. Global Livestock mRNA Vaccines Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Livestock mRNA Vaccines Market Share by Type: 2024 & 2031

Figure 4. Injectable Drug Administration Product Picture

Figure 5. Non-invasive Drug Administration Product Picture

Figure 6. Global Livestock mRNA Vaccines Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Global Livestock mRNA Vaccines Market Share by Application: 2024 & 2031

Figure 8. Cattle

Figure 9. Pigs

Figure 10. Others

Figure 11. Livestock mRNA Vaccines Report Years Considered

Figure 12. Global Livestock mRNA Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 14. Global Livestock mRNA Vaccines Revenue by Region (2020-2031) (US$ Million)

Figure 15. Global Livestock mRNA Vaccines Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 16. Global Livestock mRNA Vaccines Revenue Market Share by Region (2020-2031)

Figure 17. Global Livestock mRNA Vaccines Sales (2020-2031) & (K Dose)

Figure 18. Global Livestock mRNA Vaccines Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)

Figure 19. Global Livestock mRNA Vaccines Sales Market Share by Region (2020-2031)

Figure 20. US & Canada Livestock mRNA Vaccines Sales YoY (2020-2031) & (K Dose)

Figure 21. US & Canada Livestock mRNA Vaccines Revenue YoY (2020-2031) & (US$ Million)

Figure 22. Europe Livestock mRNA Vaccines Sales YoY (2020-2031) & (K Dose)

Figure 23. Europe Livestock mRNA Vaccines Revenue YoY (2020-2031) & (US$ Million)

Figure 24. China Livestock mRNA Vaccines Sales YoY (2020-2031) & (K Dose)

Figure 25. China Livestock mRNA Vaccines Revenue YoY (2020-2031) & (US$ Million)

Figure 26. Asia (excluding China) Livestock mRNA Vaccines Sales YoY (2020-2031) & (K Dose)

Figure 27. Asia (excluding China) Livestock mRNA Vaccines Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Livestock mRNA Vaccines Sales YoY (2020-2031) & (K Dose)

Figure 29. Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Global Livestock mRNA Vaccines Sales Share by Manufacturers (2024)

Figure 31. The Livestock mRNA Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 32. Global Livestock mRNA Vaccines Revenue Share by Manufacturers (2024)

Figure 33. The Top 5 and 10 Largest Manufacturers of Livestock mRNA Vaccines in the World: Market Share by Livestock mRNA Vaccines Revenue in 2024

Figure 34. Global Livestock mRNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. Global Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)

Figure 36. Global Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)

Figure 37. Global Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)

Figure 38. Global Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)

Figure 39. US & Canada Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)

Figure 40. US & Canada Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)

Figure 41. US & Canada Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)

Figure 42. US & Canada Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)

Figure 43. US & Canada Livestock mRNA Vaccines Revenue Share by Country (2020-2031)

Figure 44. US & Canada Livestock mRNA Vaccines Sales Share by Country (2020-2031)

Figure 45. US Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 47. Europe Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)

Figure 48. Europe Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)

Figure 49. Europe Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)

Figure 50. Europe Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)

Figure 51. Europe Livestock mRNA Vaccines Sales Share by Country (2020-2031)

Figure 52. Europe Livestock mRNA Vaccines Revenue Share by Country (2020-2031)

Figure 53. Germany Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 54. France Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 58. China Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)

Figure 59. China Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)

Figure 60. China Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)

Figure 61. China Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)

Figure 62. Asia Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)

Figure 63. Asia Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)

Figure 64. Asia Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)

Figure 65. Asia Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)

Figure 66. Asia Livestock mRNA Vaccines Revenue Share by Region (2020-2031)

Figure 67. Asia Livestock mRNA Vaccines Sales Share by Region (2020-2031)

Figure 68. Japan Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 71. Southeast Asia Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 72. India Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 73. Australia Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Livestock mRNA Vaccines Sales Market Share by Type (2020-2031)

Figure 75. Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue Market Share by Type (2020-2031)

Figure 76. Middle East, Africa and Latin America Livestock mRNA Vaccines Sales Market Share by Application (2020-2031)

Figure 77. Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue Market Share by Application (2020-2031)

Figure 78. Middle East, Africa and Latin America Livestock mRNA Vaccines Revenue Share by Country (2020-2031)

Figure 79. Middle East, Africa and Latin America Livestock mRNA Vaccines Sales Share by Country (2020-2031)

Figure 80. Brazil Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 81. Mexico Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 82. Turkey Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 83. Israel Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 84. GCC Countries Livestock mRNA Vaccines Revenue (2020-2031) & (US$ Million)

Figure 85. Value Chain

Figure 86. Livestock mRNA Vaccines Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed